Slide 1: Second Quarter 2026 Earnings
Second Quarter 2026 Earnings EARNINGS PRESENTATION July 29, 2026
Slide 2: Forward Looking Statements and Non-GAAP Financial Measures
Forward Looking Statements and Non-GAAP Financial Measures FORWARD-LOOKING STATEMENTS Statements in this presentation that are not strictly historical, including statements regarding anticipated financial results, global and regional economic conditions, industry trends, geopolitical events, anticip
Slide 3: Key Messages
Key Messages 1 Strong Q2 financial performance and execution by Fortive team, delivering +6.7% core growth, +12% adjusted EBITDA growth and +28% adjusted EPS growth Deployed ~$200 million to share repurchases in Q2, 2 bringing total share repurchases over the last four quarters to ~$2 billion, consi
Slide 4: Fortive Accelerated Strategy
Fortive Accelerated Strategy 1 2 3 Faster Profitable Disciplined Capital Build and Maintain Organic Growth Allocation Investor Trust • Innovation Acceleration • Invest in organic growth • Clear expectations and consistent • Commercial Acceleration • Smaller bolt-on M&A delivery • Recurring Customer
Slide 5: Fortive Results
Fortive Results Q2 2026 COMMENTARY • Core growth of +6.7% driven by price and Q2 2026 volume growth at both segments Revenue $1,096.8M • Adj. Gross Margin of 63%, down modestly Reported Growth +7.9% year-over-year, driven primarily by product Core Growth +6.7% mix, partially offset by operating leve
Slide 6: Intelligent Operating Solutions
Intelligent Operating Solutions Q2 2026 COMMENTARY Q2 2026 • Core revenue growth of +7.4%, driven by strong performance in professional Revenue $758.2M instrumentation, Facilities and Asset Reported Growth +8.8% Lifecycle solutions and gas detection Core Growth +7.4% • Adj. Gross Margin of ~65%, dow
Slide 7: Advanced Healthcare Solutions
Advanced Healthcare Solutions Q2 2026 COMMENTARY Q2 2026 • Core revenue growth of +5.3%, driven by solid demand for healthcare Revenue $338.6M consumables, services and software Reported Growth +6.0% and modest growth in capital Core Growth +5.3% equipment • Adj. Gross Margin of ~58%, down modestly
Slide 8: Balance Sheet & Capital Allocation
Balance Sheet & Capital Allocation Q2 2026 COMMENTARY & CAPITAL ALLOCATION Balance Sheet As of July 3, 2026 HIGHLIGHTS Cash and equivalents $0.37B • Deployed ~$200M towards share repurchase in Q2, representing ~3M Gross Debt, principal amounts $3.53B shares, at an average price of $59.54 Net Debt $3
Slide 9: FY 2026 Guidance
FY 2026 Guidance Adj. EPS | FY 2026 $2.95 to $3.05 Guidance as of date of Q2 2026 earnings call: July 29, 2026. 9
Slide 10: Fortive Accelerated
Fortive Accelerated Innovating essential technologies to keep our world safe and productive 10
Slide 11: Appendix & Supplemental Reconciliation Data
Appendix & Supplemental Reconciliation Data 11
Slide 12: Core Revenue Growth
CORE REVENUE GROWTH Three Months Ended July 3, 2026 Intelligent Advanced Operating Healthcare Total Fortive Solutions Solutions Total revenue growth (GAAP) 8.8 % 6.0 % 7.9 % Excluding impact of: Acquisitions and divestitures (0.4) % (0.1)% (0.3)% Currency exchange rates (1.0)% (0.6)% (0.9)% Core rev
Slide 13: Adjusted Gross Profit and Adjusted Gross Profit Margin
ADJUSTED GROSS PROFIT AND ADJUSTED GROSS PROFIT MARGIN Three Months Ended July 3, 2026 Three Months Ended June 27, 2025 $ in millions Intelligent Advanced Total Intelligent Advanced Total Operating Healthcare Fortive Operating Healthcare Fortive Solutions Solutions Solutions Solutions Revenue (GAAP)
Slide 14: Adjusted EBITDA and Adjusted EBITDA Margin from Continuing Operations
ADJUSTED EBITDA AND ADJUSTED EBITDA MARGIN FROM CONTINUING OPERATIONS Three Months Ended $ in millions July 3, 2026 April 3, 2026 December 31, 2025 September 26, 2025 June 27, 2025 Revenue (GAAP) $ 1,096.8 $ 1,069.4 $ 1,122.5 $ 1,027.2 $ 1,016.4 Net Earnings from Continuing Operations (GAAP) $ 157.3
Slide 15: Operating Profit to Adjusted EBITDA and Adjusted Margin Bridge
OPERATING PROFIT & OPERATING PROFIT MARGIN TO ADJUSTED EBITDA AND ADJUSTED MARGIN BRIDGE Three Months Ended $ in millions July 3, 2026 June 27, 2025 Revenue (GAAP) $ 1,096.8 $ 1,016.4 Operating Profit (GAAP) $ 209.9 $ 169.8 Amortization of acquisition-related intangible assets 91.5 91.6 Acquisition,
Slide 16: Segment Adjusted EBITDA and Segment Adjusted EBITDA Margin
SEGMENT ADJUSTED EBITDA AND SEGMENT ADJUSTED EBITDA MARGIN Three Months Ended July 3, 2026 Three Months Ended June 27, 2025 $ in millions Intelligent Advanced Corporate Total Intelligent Advanced Corporate Total Operating Healthcare Fortive Operating Healthcare Fortive Solutions Solutions Solutions
Slide 17: Adjusted Net Earnings and Adjusted Diluted EPS from Continuing Operations
ADJUSTED NET EARNINGS AND ADJUSTED DILUTED EPS FROM CONTINUING OPERATIONS Three Months Ended $ in millions, except per share amounts July 3, 2026 June 27, 2025 Per share Per share value value Net Earnings and Earnings Per Share from Continuing Operations (GAAP) $ 157.3 $ 0.51 $ 111.6 $ 0.33 Pretax a
Slide 18: Debt Principal, Net Debt, and Leverage
DEBT PRINCIPAL, NET DEBT, AND LEVERAGE $ in millions July 3, 2026 Current portion of long-term debt, carrying value $ — Long-term debt, carrying value 3,509.3 Debt, net carrying value (GAAP) 3,509.3 Plus: Aggregate unamortized debt discounts, premiums, and issuance costs 17.9 Debt, principal amounts
Slide 19: Free Cash Flow from Continuing Operations
FREE CASH FLOW FROM CONTINUING OPERATIONS Three Months Ended Trailing Twelve $ in millions July 3, 2026 April 3, 2026 December 31, 2025 September 26, 2025 Months Operating Cash Flows from Continuing Operations (GAAP) $ 298.7 $ 220.4 $ 344.2 $ 294.7 $ 1,158.0 Less: Purchases of property, plant & equi
Slide 20: @ FORTIVE © Fortive 2026
20 @ FORTIVE © Fortive 2026